SMFRW

Sema4 (SMFRW)

Sema4 Holdings Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SMFRW

1 2 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2023/01/09	22:30	GlobeNewswire Inc.	Sema4 Announces Name Change to GeneDx and Provides Preliminary 2022 Financial Results and 2023 Guidance	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/12/30	22:30	GlobeNewswire Inc.	Sema4\|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/12/05	22:00	GlobeNewswire Inc.	New Research from Sema4\|GeneDx Highlights the Importance of Rapid Exome Sequencing for Diagnosing Mitochondrial Diseases in the NICU	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/11/14	22:02	GlobeNewswire Inc.	Sema4 Reports Third Quarter 2022 Financial Results and New Strategic Direction	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/11/05	05:05	GlobeNewswire Inc.	Sema4 to Report Third Quarter 2022 Financial Results on Monday, November 14th, 2022	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/10/31	22:00	GlobeNewswire Inc.	Sema4\|GeneDx Commends New Evidence-Based Guidelines from the National Society of Genetic Counselors Recommending Exome Sequencing as a First-Tier Genetic Test for Unexplained Epilepsies	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/10/27	21:00	GlobeNewswire Inc.	Sema4\|GeneDx Announces Results from Phase 1 of SeqFirst Study, Demonstrating Broad Utility of Rapid Whole Genome Sequencing for Critically Ill Newborns	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/10/26	21:00	GlobeNewswire Inc.	Sema4\|GeneDx collaborates on new research demonstrating genome and exome sequencing deliver more diagnostic certainty than multi-gene panels	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/10/13	21:00	GlobeNewswire Inc.	Study Demonstrates the Utility of Exome Sequencing for Diagnosing Autism Spectrum Disorders	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/10/05	21:00	GlobeNewswire Inc.	Sema4\|GeneDx To Provide Whole Genome Sequencing and Interpretation Services for Landmark Genomic Newborn Screening Study	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/08/26	21:00	GlobeNewswire Inc.	Sema4 Appoints Healthcare and Diagnostics Industry Veteran Kevin Feeley as Chief Financial Officer	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/08/16	05:05	GlobeNewswire Inc.	Sema4 Announces Continued Restructuring, Business Highlights, and Reports Second Quarter 2022 Financial Results	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/08/16	05:05	GlobeNewswire Inc.	Sema4 Announces Changes to its Research & Development Leadership	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/07/26	21:00	GlobeNewswire Inc.	Sema4 to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/06/15	05:30	GlobeNewswire Inc.	Sema4 Announces Chief Financial Officer Transition Plan	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/06/01	21:30	GlobeNewswire Inc.	Avera Health and Sema4 Announce Data-driven Study to Advance Cancer Treatment Across the Avera Service Area	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/05/26	21:00	GlobeNewswire Inc.	Sema4 to Participate at Two Investor Conferences in June 2022	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/05/13	05:05	GlobeNewswire Inc.	Sema4 Reports First Quarter 2022 Financial Results and Business Highlights	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/05/05	05:05	GlobeNewswire Inc.	Sema4 Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/05/02	20:45	GlobeNewswire Inc.	Sema4 Announces the Completion of the GeneDx Acquisition and a Streamlined Leadership Structure to Accelerate Growth of its Diagnostic and Clinical Data Platforms	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/04/27	05:05	GlobeNewswire Inc.	Sema4 to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/04/06	21:00	GlobeNewswire Inc.	Sema4 Achieves HITRUST CSF Certification	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/04/05	21:00	GlobeNewswire Inc.	Sema4 and Mount Sinai Use Integrative Network Analysis to Identify Potential New Lung Cancer Therapy	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/03/16	21:00	GlobeNewswire Inc.	Sema4 Announces Nationwide Expansion of Disparity Study to Deliver Precision Oncology Care to Underserved Communities	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/03/15	05:05	GlobeNewswire Inc.	Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/03/08	22:00	GlobeNewswire Inc.	Sema4 Named to Fast Company’s Annual List of the World’s Most Innovative Companies for 2022	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/02/23	06:05	GlobeNewswire Inc.	Sema4 to Report Fourth Quarter and Full Year 2021 Financial Results and Participate in Investor Conferences in March 2022	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/02/22	22:00	GlobeNewswire Inc.	Sema4 and BioSymetrics Partner on Data-Driven Drug Discovery to Advance Precision Medicine	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/02/04	06:05	GlobeNewswire Inc.	Sema4 to Participate at Two Upcoming Investor Conferences in February	NASDAQ:SMFRW	Sema4 Holdings Corporation
2022/02/01	21:30	GlobeNewswire Inc.	Sema4 Announces Plans to Strengthen its Market Access Team to Drive Improved Commercial and Reimbursement Capabilities	NASDAQ:SMFRW	Sema4 Holdings Corporation